MEB 5.45% 5.8¢ medibio limited

Ametus Study

  1. 52 Posts.
    The Ametus study shows a potential of USD100m if MEB achieves 5% of the market in the US, with the first objective test for depression. Can use existing reimbursement codes so the route to market is simplified, and they have JHU to validate the science in the US. They just keep ticking boxes....
 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist
(20min delay)
Last
5.8¢
Change
0.00(5.45%)
Mkt cap $12.02M
Open High Low Value Volume
5.6¢ 5.8¢ 5.6¢ $2.88K 50K

Buyers (Bids)

No. Vol. Price($)
3 130150 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 25520 2
Last update - 13.41pm 19/10/2018 (20 minute delay) ?
MEB (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.